nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—Protein Kinase Inhibitors—Nilotinib—hematologic cancer	0.181	0.5	CiPCiCtD
Sunitinib—Protein Kinase Inhibitors—Ruxolitinib—hematologic cancer	0.181	0.5	CiPCiCtD
Sunitinib—DAPK1—hematologic cancer	0.0294	0.147	CbGaD
Sunitinib—FLT3—hematologic cancer	0.0273	0.137	CbGaD
Sunitinib—MAP2K1—hematologic cancer	0.0207	0.104	CbGaD
Sunitinib—FGR—hematologic cancer	0.0207	0.104	CbGaD
Sunitinib—RET—hematologic cancer	0.0176	0.0881	CbGaD
Sunitinib—JAK2—hematologic cancer	0.0157	0.0785	CbGaD
Sunitinib—ALK—hematologic cancer	0.0148	0.0738	CbGaD
Sunitinib—CSF1R—hematologic cancer	0.014	0.07	CbGaD
Sunitinib—PDGFRB—hematologic cancer	0.0122	0.0611	CbGaD
Sunitinib—PDGFRA—hematologic cancer	0.0119	0.0595	CbGaD
Sunitinib—KIT—hematologic cancer	0.00873	0.0437	CbGaD
Sunitinib—GRK1—Ruxolitinib—hematologic cancer	0.00771	0.0304	CbGbCtD
Sunitinib—MARK2—Ruxolitinib—hematologic cancer	0.00771	0.0304	CbGbCtD
Sunitinib—DCLK3—Ruxolitinib—hematologic cancer	0.00771	0.0304	CbGbCtD
Sunitinib—HIPK2—Ruxolitinib—hematologic cancer	0.00771	0.0304	CbGbCtD
Sunitinib—GRK7—Ruxolitinib—hematologic cancer	0.00771	0.0304	CbGbCtD
Sunitinib—DAPK2—Ruxolitinib—hematologic cancer	0.00771	0.0304	CbGbCtD
Sunitinib—DAPK3—Ruxolitinib—hematologic cancer	0.00771	0.0304	CbGbCtD
Sunitinib—CLK2—Ruxolitinib—hematologic cancer	0.00771	0.0304	CbGbCtD
Sunitinib—DYRK1A—Ruxolitinib—hematologic cancer	0.00557	0.0219	CbGbCtD
Sunitinib—CAMK2G—Ruxolitinib—hematologic cancer	0.00557	0.0219	CbGbCtD
Sunitinib—TYK2—Ruxolitinib—hematologic cancer	0.00557	0.0219	CbGbCtD
Sunitinib—PHKG2—Ruxolitinib—hematologic cancer	0.00557	0.0219	CbGbCtD
Sunitinib—MAST1—Ruxolitinib—hematologic cancer	0.00557	0.0219	CbGbCtD
Sunitinib—STK16—Ruxolitinib—hematologic cancer	0.00557	0.0219	CbGbCtD
Sunitinib—ROCK1—Ruxolitinib—hematologic cancer	0.00557	0.0219	CbGbCtD
Sunitinib—LRRK2—Ruxolitinib—hematologic cancer	0.00557	0.0219	CbGbCtD
Sunitinib—ABCG2—hematologic cancer	0.00483	0.0242	CbGaD
Sunitinib—FGFR2—Thalidomide—hematologic cancer	0.00468	0.0184	CbGbCtD
Sunitinib—JAK2—Ruxolitinib—hematologic cancer	0.00443	0.0174	CbGbCtD
Sunitinib—MAP3K7—Ruxolitinib—hematologic cancer	0.00443	0.0174	CbGbCtD
Sunitinib—NUAK2—Ruxolitinib—hematologic cancer	0.00443	0.0174	CbGbCtD
Sunitinib—BMP2K—Ruxolitinib—hematologic cancer	0.00443	0.0174	CbGbCtD
Sunitinib—MAP4K1—Nilotinib—hematologic cancer	0.00427	0.0168	CbGbCtD
Sunitinib—NTRK1—Imatinib—hematologic cancer	0.00393	0.0155	CbGbCtD
Sunitinib—JAK2—Dasatinib—hematologic cancer	0.00378	0.0149	CbGbCtD
Sunitinib—FYN—Dasatinib—hematologic cancer	0.00378	0.0149	CbGbCtD
Sunitinib—MAP3K3—Ruxolitinib—hematologic cancer	0.0037	0.0146	CbGbCtD
Sunitinib—PLK4—Ruxolitinib—hematologic cancer	0.0037	0.0146	CbGbCtD
Sunitinib—TAOK3—Ruxolitinib—hematologic cancer	0.0037	0.0146	CbGbCtD
Sunitinib—RET—Ruxolitinib—hematologic cancer	0.0032	0.0126	CbGbCtD
Sunitinib—IRAK1—Ruxolitinib—hematologic cancer	0.0032	0.0126	CbGbCtD
Sunitinib—MAP3K2—Ruxolitinib—hematologic cancer	0.0032	0.0126	CbGbCtD
Sunitinib—MAP3K3—Dasatinib—hematologic cancer	0.00316	0.0124	CbGbCtD
Sunitinib—YES1—Dasatinib—hematologic cancer	0.00316	0.0124	CbGbCtD
Sunitinib—MAP4K5—Dasatinib—hematologic cancer	0.00316	0.0124	CbGbCtD
Sunitinib—FGR—Nilotinib—hematologic cancer	0.00309	0.0122	CbGbCtD
Sunitinib—HIPK4—Imatinib—hematologic cancer	0.00301	0.0118	CbGbCtD
Sunitinib—BLK—Nilotinib—hematologic cancer	0.00273	0.0108	CbGbCtD
Sunitinib—EPHB6—Nilotinib—hematologic cancer	0.00273	0.0108	CbGbCtD
Sunitinib—MAP3K2—Dasatinib—hematologic cancer	0.00273	0.0107	CbGbCtD
Sunitinib—FGR—Dasatinib—hematologic cancer	0.00273	0.0107	CbGbCtD
Sunitinib—PDGFRA—Imatinib—hematologic cancer	0.0027	0.0106	CbGbCtD
Sunitinib—KIT—Imatinib—hematologic cancer	0.0027	0.0106	CbGbCtD
Sunitinib—CSF1R—Imatinib—hematologic cancer	0.0027	0.0106	CbGbCtD
Sunitinib—PDGFRB—Imatinib—hematologic cancer	0.00246	0.00968	CbGbCtD
Sunitinib—KIT—Nilotinib—hematologic cancer	0.00245	0.00966	CbGbCtD
Sunitinib—PDGFRA—Nilotinib—hematologic cancer	0.00245	0.00966	CbGbCtD
Sunitinib—CSF1R—Nilotinib—hematologic cancer	0.00245	0.00966	CbGbCtD
Sunitinib—EPHB6—Dasatinib—hematologic cancer	0.00241	0.0095	CbGbCtD
Sunitinib—BLK—Dasatinib—hematologic cancer	0.00241	0.0095	CbGbCtD
Sunitinib—PDGFRB—Nilotinib—hematologic cancer	0.00223	0.00879	CbGbCtD
Sunitinib—MAP2K5—Nilotinib—hematologic cancer	0.00223	0.00879	CbGbCtD
Sunitinib—PDGFRA—Dasatinib—hematologic cancer	0.00217	0.00854	CbGbCtD
Sunitinib—CSF1R—Dasatinib—hematologic cancer	0.00217	0.00854	CbGbCtD
Sunitinib—KIT—Dasatinib—hematologic cancer	0.00217	0.00854	CbGbCtD
Sunitinib—MAP3K19—Ruxolitinib—hematologic cancer	0.00213	0.00838	CbGbCtD
Sunitinib—ABCC4—Tioguanine—hematologic cancer	0.00202	0.00795	CbGbCtD
Sunitinib—ABCB1—hematologic cancer	0.00201	0.0101	CbGaD
Sunitinib—MAP2K5—Dasatinib—hematologic cancer	0.00197	0.00777	CbGbCtD
Sunitinib—PDGFRB—Dasatinib—hematologic cancer	0.00197	0.00777	CbGbCtD
Sunitinib—MAP3K19—Dasatinib—hematologic cancer	0.00181	0.00714	CbGbCtD
Sunitinib—ABCG2—Clofarabine—hematologic cancer	0.000993	0.00391	CbGbCtD
Sunitinib—ABCC4—Mercaptopurine—hematologic cancer	0.000839	0.0033	CbGbCtD
Sunitinib—ABCC2—Daunorubicin—hematologic cancer	0.000644	0.00254	CbGbCtD
Sunitinib—ABCG2—Daunorubicin—hematologic cancer	0.000582	0.00229	CbGbCtD
Sunitinib—ABCG2—Teniposide—hematologic cancer	0.000506	0.00199	CbGbCtD
Sunitinib—ABCG2—Cladribine—hematologic cancer	0.000485	0.00191	CbGbCtD
Sunitinib—ABCG2—Imatinib—hematologic cancer	0.000446	0.00176	CbGbCtD
Sunitinib—ABCG2—Nilotinib—hematologic cancer	0.000405	0.0016	CbGbCtD
Sunitinib—ABCG2—Dasatinib—hematologic cancer	0.000358	0.00141	CbGbCtD
Sunitinib—ABCB1—Lenalidomide—hematologic cancer	0.000358	0.00141	CbGbCtD
Sunitinib—ABCG2—Mitoxantrone—hematologic cancer	0.000354	0.00139	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.000345	0.00136	CbGbCtD
Sunitinib—CYP3A7—Ifosfamide—hematologic cancer	0.000345	0.00136	CbGbCtD
Sunitinib—CYP3A7—Imatinib—hematologic cancer	0.000329	0.0013	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.000329	0.0013	CbGbCtD
Sunitinib—CYP3A5—Daunorubicin—hematologic cancer	0.000323	0.00127	CbGbCtD
Sunitinib—ABCC2—Irinotecan—hematologic cancer	0.000308	0.00121	CbGbCtD
Sunitinib—CYP3A5—Thalidomide—hematologic cancer	0.000294	0.00116	CbGbCtD
Sunitinib—CYP3A5—Teniposide—hematologic cancer	0.00028	0.0011	CbGbCtD
Sunitinib—ABCG2—Irinotecan—hematologic cancer	0.000279	0.0011	CbGbCtD
Sunitinib—ABCC4—Methotrexate—hematologic cancer	0.000274	0.00108	CbGbCtD
Sunitinib—ABCC2—Vinblastine—hematologic cancer	0.000274	0.00108	CbGbCtD
Sunitinib—ABCC2—Vincristine—hematologic cancer	0.000269	0.00106	CbGbCtD
Sunitinib—CYP3A5—Ifosfamide—hematologic cancer	0.000259	0.00102	CbGbCtD
Sunitinib—ABCC2—Cisplatin—hematologic cancer	0.000251	0.000989	CbGbCtD
Sunitinib—CYP3A5—Imatinib—hematologic cancer	0.000247	0.000973	CbGbCtD
Sunitinib—ABCC2—Etoposide—hematologic cancer	0.000247	0.000972	CbGbCtD
Sunitinib—ABCG2—Vincristine—hematologic cancer	0.000244	0.000959	CbGbCtD
Sunitinib—ABCG2—Cisplatin—hematologic cancer	0.000227	0.000894	CbGbCtD
Sunitinib—ABCG2—Etoposide—hematologic cancer	0.000223	0.000878	CbGbCtD
Sunitinib—CYP3A4—Bexarotene—hematologic cancer	0.000215	0.000845	CbGbCtD
Sunitinib—ABCB1—Daunorubicin—hematologic cancer	0.00021	0.000826	CbGbCtD
Sunitinib—CYP3A7—Irinotecan—hematologic cancer	0.000206	0.00081	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.000206	0.00081	CbGbCtD
Sunitinib—ABCB1—Alitretinoin—hematologic cancer	0.000206	0.00081	CbGbCtD
Sunitinib—ABCC2—Dexamethasone—hematologic cancer	0.000203	0.000799	CbGbCtD
Sunitinib—CYP3A4—Busulfan—hematologic cancer	0.000199	0.000785	CbGbCtD
Sunitinib—CYP3A4—Lomustine—hematologic cancer	0.000199	0.000785	CbGbCtD
Sunitinib—CYP3A5—Dasatinib—hematologic cancer	0.000198	0.000781	CbGbCtD
Sunitinib—ABCG2—Dexamethasone—hematologic cancer	0.000183	0.000722	CbGbCtD
Sunitinib—CYP3A7—Vincristine—hematologic cancer	0.00018	0.000708	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00018	0.000708	CbGbCtD
Sunitinib—CYP3A4—Thiotepa—hematologic cancer	0.000178	0.0007	CbGbCtD
Sunitinib—ABCC2—Doxorubicin—hematologic cancer	0.000168	0.000663	CbGbCtD
Sunitinib—ABCC2—Methotrexate—hematologic cancer	0.000163	0.000642	CbGbCtD
Sunitinib—ABCB1—Imatinib—hematologic cancer	0.000161	0.000633	CbGbCtD
Sunitinib—CYP3A5—Irinotecan—hematologic cancer	0.000154	0.000608	CbGbCtD
Sunitinib—ABCG2—Doxorubicin—hematologic cancer	0.000152	0.000599	CbGbCtD
Sunitinib—ABCG2—Methotrexate—hematologic cancer	0.000147	0.00058	CbGbCtD
Sunitinib—ABCB1—Nilotinib—hematologic cancer	0.000146	0.000575	CbGbCtD
Sunitinib—ABCB1—Vinorelbine—hematologic cancer	0.000145	0.00057	CbGbCtD
Sunitinib—CYP3A4—Methoxsalen—hematologic cancer	0.000138	0.000544	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.000135	0.000533	CbGbCtD
Sunitinib—CYP3A7—Dexamethasone—hematologic cancer	0.000135	0.000533	CbGbCtD
Sunitinib—CYP3A5—Vincristine—hematologic cancer	0.000135	0.000531	CbGbCtD
Sunitinib—CYP3A4—Bortezomib—hematologic cancer	0.000132	0.000518	CbGbCtD
Sunitinib—ABCB1—Dasatinib—hematologic cancer	0.000129	0.000508	CbGbCtD
Sunitinib—ABCB1—Mitoxantrone—hematologic cancer	0.000128	0.000502	CbGbCtD
Sunitinib—CYP3A4—Daunorubicin—hematologic cancer	0.000126	0.000495	CbGbCtD
Sunitinib—CYP3A5—Etoposide—hematologic cancer	0.000124	0.000487	CbGbCtD
Sunitinib—ABCB1—Betamethasone—hematologic cancer	0.000114	0.000448	CbGbCtD
Sunitinib—ABCB1—Gemcitabine—hematologic cancer	0.000113	0.000444	CbGbCtD
Sunitinib—ABCB1—Prednisolone—hematologic cancer	0.000112	0.000442	CbGbCtD
Sunitinib—CYP3A4—Cytarabine—hematologic cancer	0.000111	0.000437	CbGbCtD
Sunitinib—CYP3A4—Teniposide—hematologic cancer	0.000109	0.00043	CbGbCtD
Sunitinib—ABCB1—Prednisone—hematologic cancer	0.000106	0.000417	CbGbCtD
Sunitinib—CYP3A5—Dexamethasone—hematologic cancer	0.000102	0.0004	CbGbCtD
Sunitinib—CYP3A4—Ifosfamide—hematologic cancer	0.000101	0.000397	CbGbCtD
Sunitinib—ABCB1—Irinotecan—hematologic cancer	0.0001	0.000395	CbGbCtD
Sunitinib—CYP3A4—Imatinib—hematologic cancer	9.64e-05	0.000379	CbGbCtD
Sunitinib—CYP3A4—Ruxolitinib—hematologic cancer	9.07e-05	0.000357	CbGbCtD
Sunitinib—ABCB1—Vinblastine—hematologic cancer	8.93e-05	0.000352	CbGbCtD
Sunitinib—ABCB1—Vincristine—hematologic cancer	8.78e-05	0.000346	CbGbCtD
Sunitinib—CYP3A4—Nilotinib—hematologic cancer	8.76e-05	0.000345	CbGbCtD
Sunitinib—CYP3A4—Vinorelbine—hematologic cancer	8.68e-05	0.000342	CbGbCtD
Sunitinib—ABCB1—Cisplatin—hematologic cancer	8.19e-05	0.000322	CbGbCtD
Sunitinib—ABCB1—Etoposide—hematologic cancer	8.05e-05	0.000317	CbGbCtD
Sunitinib—CYP3A4—Triamcinolone—hematologic cancer	7.94e-05	0.000313	CbGbCtD
Sunitinib—OXSR1—Ponatinib—Nilotinib—hematologic cancer	7.79e-05	0.0645	CbGdCrCtD
Sunitinib—CYP3A4—Dasatinib—hematologic cancer	7.74e-05	0.000305	CbGbCtD
Sunitinib—CYP3A4—Mitoxantrone—hematologic cancer	7.64e-05	0.000301	CbGbCtD
Sunitinib—CYP3A4—Betamethasone—hematologic cancer	6.81e-05	0.000268	CbGbCtD
Sunitinib—CYP3A4—Prednisolone—hematologic cancer	6.72e-05	0.000265	CbGbCtD
Sunitinib—ABCB1—Dexamethasone—hematologic cancer	6.62e-05	0.00026	CbGbCtD
Sunitinib—CYP3A4—Prednisone—hematologic cancer	6.35e-05	0.00025	CbGbCtD
Sunitinib—CYP3A4—Irinotecan—hematologic cancer	6.02e-05	0.000237	CbGbCtD
Sunitinib—OXSR1—Ponatinib—Imatinib—hematologic cancer	5.9e-05	0.0489	CbGdCrCtD
Sunitinib—ABCB1—Doxorubicin—hematologic cancer	5.49e-05	0.000216	CbGbCtD
Sunitinib—CYP3A4—Vinblastine—hematologic cancer	5.35e-05	0.000211	CbGbCtD
Sunitinib—ABCB1—Methotrexate—hematologic cancer	5.32e-05	0.000209	CbGbCtD
Sunitinib—CYP3A4—Vincristine—hematologic cancer	5.26e-05	0.000207	CbGbCtD
Sunitinib—MAP3K2—blood—hematologic cancer	5.1e-05	0.00126	CbGeAlD
Sunitinib—MERTK—testis—hematologic cancer	5.09e-05	0.00126	CbGeAlD
Sunitinib—IRAK4—bone marrow—hematologic cancer	5.08e-05	0.00126	CbGeAlD
Sunitinib—MAP3K7—blood—hematologic cancer	5.05e-05	0.00125	CbGeAlD
Sunitinib—CSNK1A1—lung—hematologic cancer	5.05e-05	0.00125	CbGeAlD
Sunitinib—CHEK2—lymph node—hematologic cancer	5.05e-05	0.00125	CbGeAlD
Sunitinib—NUAK1—lymph node—hematologic cancer	5.05e-05	0.00125	CbGeAlD
Sunitinib—CLK1—lung—hematologic cancer	5.02e-05	0.00124	CbGeAlD
Sunitinib—OXSR1—lymph node—hematologic cancer	5.01e-05	0.00124	CbGeAlD
Sunitinib—INSR—lymph node—hematologic cancer	5.01e-05	0.00124	CbGeAlD
Sunitinib—SNRK—lymph node—hematologic cancer	5.01e-05	0.00124	CbGeAlD
Sunitinib—MAP4K4—testis—hematologic cancer	5e-05	0.00124	CbGeAlD
Sunitinib—TBK1—blood—hematologic cancer	4.99e-05	0.00124	CbGeAlD
Sunitinib—MAP4K5—gonad—hematologic cancer	4.99e-05	0.00124	CbGeAlD
Sunitinib—MAP3K3—gonad—hematologic cancer	4.99e-05	0.00124	CbGeAlD
Sunitinib—MAP2K2—bone marrow—hematologic cancer	4.97e-05	0.00123	CbGeAlD
Sunitinib—ULK3—bone marrow—hematologic cancer	4.97e-05	0.00123	CbGeAlD
Sunitinib—NUAK2—testis—hematologic cancer	4.96e-05	0.00123	CbGeAlD
Sunitinib—TYK2—blood—hematologic cancer	4.96e-05	0.00123	CbGeAlD
Sunitinib—MAP3K2—bone marrow—hematologic cancer	4.93e-05	0.00122	CbGeAlD
Sunitinib—FLT3—testis—hematologic cancer	4.93e-05	0.00122	CbGeAlD
Sunitinib—MAP3K12—testis—hematologic cancer	4.93e-05	0.00122	CbGeAlD
Sunitinib—STK38—lymph node—hematologic cancer	4.93e-05	0.00122	CbGeAlD
Sunitinib—RPS6KA2—lymph node—hematologic cancer	4.93e-05	0.00122	CbGeAlD
Sunitinib—CAMK2G—lung—hematologic cancer	4.92e-05	0.00122	CbGeAlD
Sunitinib—BMP2K—lung—hematologic cancer	4.92e-05	0.00122	CbGeAlD
Sunitinib—IRAK1—blood—hematologic cancer	4.9e-05	0.00121	CbGeAlD
Sunitinib—MAP3K7—bone marrow—hematologic cancer	4.89e-05	0.00121	CbGeAlD
Sunitinib—AURKC—lymph node—hematologic cancer	4.89e-05	0.00121	CbGeAlD
Sunitinib—LRRK2—lung—hematologic cancer	4.88e-05	0.00121	CbGeAlD
Sunitinib—RPS6KA3—testis—hematologic cancer	4.86e-05	0.00121	CbGeAlD
Sunitinib—PKN1—lymph node—hematologic cancer	4.85e-05	0.0012	CbGeAlD
Sunitinib—CSNK1G2—lymph node—hematologic cancer	4.85e-05	0.0012	CbGeAlD
Sunitinib—TBK1—bone marrow—hematologic cancer	4.83e-05	0.0012	CbGeAlD
Sunitinib—FLT1—gonad—hematologic cancer	4.83e-05	0.0012	CbGeAlD
Sunitinib—MAP2K1—testis—hematologic cancer	4.83e-05	0.0012	CbGeAlD
Sunitinib—CYP3A4—Etoposide—hematologic cancer	4.82e-05	0.00019	CbGbCtD
Sunitinib—PRKAA1—lung—hematologic cancer	4.81e-05	0.00119	CbGeAlD
Sunitinib—RPS6KB1—blood—hematologic cancer	4.8e-05	0.00119	CbGeAlD
Sunitinib—TYK2—bone marrow—hematologic cancer	4.8e-05	0.00119	CbGeAlD
Sunitinib—PRPF4—lymph node—hematologic cancer	4.78e-05	0.00119	CbGeAlD
Sunitinib—RET—blood—hematologic cancer	4.78e-05	0.00118	CbGeAlD
Sunitinib—FGR—blood—hematologic cancer	4.78e-05	0.00118	CbGeAlD
Sunitinib—CSNK1A1—testis—hematologic cancer	4.76e-05	0.00118	CbGeAlD
Sunitinib—KIT—hematopoietic system—hematologic cancer	4.76e-05	0.00118	CbGeAlD
Sunitinib—PTK2B—lung—hematologic cancer	4.75e-05	0.00118	CbGeAlD
Sunitinib—FLT4—lung—hematologic cancer	4.74e-05	0.00118	CbGeAlD
Sunitinib—IRAK1—bone marrow—hematologic cancer	4.74e-05	0.00118	CbGeAlD
Sunitinib—CLK1—testis—hematologic cancer	4.73e-05	0.00117	CbGeAlD
Sunitinib—PRPF4B—lymph node—hematologic cancer	4.71e-05	0.00117	CbGeAlD
Sunitinib—FGFR1—lung—hematologic cancer	4.68e-05	0.00116	CbGeAlD
Sunitinib—CSNK1E—lung—hematologic cancer	4.68e-05	0.00116	CbGeAlD
Sunitinib—RPS6KB1—bone marrow—hematologic cancer	4.65e-05	0.00115	CbGeAlD
Sunitinib—STK39—lymph node—hematologic cancer	4.65e-05	0.00115	CbGeAlD
Sunitinib—CAMK2G—testis—hematologic cancer	4.65e-05	0.00115	CbGeAlD
Sunitinib—BMP2K—testis—hematologic cancer	4.65e-05	0.00115	CbGeAlD
Sunitinib—PDGFRB—hematopoietic system—hematologic cancer	4.64e-05	0.00115	CbGeAlD
Sunitinib—FGR—bone marrow—hematologic cancer	4.62e-05	0.00115	CbGeAlD
Sunitinib—YES1—gonad—hematologic cancer	4.61e-05	0.00114	CbGeAlD
Sunitinib—IRAK4—lung—hematologic cancer	4.61e-05	0.00114	CbGeAlD
Sunitinib—LRRK2—testis—hematologic cancer	4.6e-05	0.00114	CbGeAlD
Sunitinib—CSNK2A1—lymph node—hematologic cancer	4.59e-05	0.00114	CbGeAlD
Sunitinib—SLK—blood—hematologic cancer	4.58e-05	0.00114	CbGeAlD
Sunitinib—STK10—gonad—hematologic cancer	4.57e-05	0.00113	CbGeAlD
Sunitinib—PRKAA1—testis—hematologic cancer	4.54e-05	0.00113	CbGeAlD
Sunitinib—FGFR2—blood—hematologic cancer	4.54e-05	0.00113	CbGeAlD
Sunitinib—MYLK—lymph node—hematologic cancer	4.53e-05	0.00112	CbGeAlD
Sunitinib—PDGFRA—gonad—hematologic cancer	4.52e-05	0.00112	CbGeAlD
Sunitinib—JAK2—blood—hematologic cancer	4.51e-05	0.00112	CbGeAlD
Sunitinib—ULK3—lung—hematologic cancer	4.5e-05	0.00112	CbGeAlD
Sunitinib—MAP2K2—lung—hematologic cancer	4.5e-05	0.00112	CbGeAlD
Sunitinib—PTK2B—testis—hematologic cancer	4.49e-05	0.00111	CbGeAlD
Sunitinib—FLT4—testis—hematologic cancer	4.47e-05	0.00111	CbGeAlD
Sunitinib—MAP3K2—lung—hematologic cancer	4.47e-05	0.00111	CbGeAlD
Sunitinib—PLK4—lymph node—hematologic cancer	4.47e-05	0.00111	CbGeAlD
Sunitinib—FYN—blood—hematologic cancer	4.45e-05	0.0011	CbGeAlD
Sunitinib—STK4—lymph node—hematologic cancer	4.44e-05	0.0011	CbGeAlD
Sunitinib—SLK—bone marrow—hematologic cancer	4.43e-05	0.0011	CbGeAlD
Sunitinib—MAP3K7—lung—hematologic cancer	4.43e-05	0.0011	CbGeAlD
Sunitinib—CSNK1E—testis—hematologic cancer	4.41e-05	0.00109	CbGeAlD
Sunitinib—FGFR1—testis—hematologic cancer	4.41e-05	0.00109	CbGeAlD
Sunitinib—TBK1—lung—hematologic cancer	4.38e-05	0.00109	CbGeAlD
Sunitinib—JAK2—bone marrow—hematologic cancer	4.37e-05	0.00108	CbGeAlD
Sunitinib—PHKG2—lymph node—hematologic cancer	4.36e-05	0.00108	CbGeAlD
Sunitinib—MAP3K3—blood—hematologic cancer	4.35e-05	0.00108	CbGeAlD
Sunitinib—MAP4K5—blood—hematologic cancer	4.35e-05	0.00108	CbGeAlD
Sunitinib—TYK2—lung—hematologic cancer	4.35e-05	0.00108	CbGeAlD
Sunitinib—IRAK4—testis—hematologic cancer	4.35e-05	0.00108	CbGeAlD
Sunitinib—STK24—lymph node—hematologic cancer	4.34e-05	0.00108	CbGeAlD
Sunitinib—FYN—bone marrow—hematologic cancer	4.31e-05	0.00107	CbGeAlD
Sunitinib—IRAK1—lung—hematologic cancer	4.29e-05	0.00106	CbGeAlD
Sunitinib—DAPK2—lymph node—hematologic cancer	4.29e-05	0.00106	CbGeAlD
Sunitinib—ULK3—testis—hematologic cancer	4.25e-05	0.00105	CbGeAlD
Sunitinib—MAP2K2—testis—hematologic cancer	4.25e-05	0.00105	CbGeAlD
Sunitinib—STK16—lymph node—hematologic cancer	4.22e-05	0.00105	CbGeAlD
Sunitinib—MAP3K2—testis—hematologic cancer	4.22e-05	0.00105	CbGeAlD
Sunitinib—RPS6KB1—lung—hematologic cancer	4.21e-05	0.00104	CbGeAlD
Sunitinib—MAP4K5—bone marrow—hematologic cancer	4.21e-05	0.00104	CbGeAlD
Sunitinib—MAP3K3—bone marrow—hematologic cancer	4.21e-05	0.00104	CbGeAlD
Sunitinib—FLT1—blood—hematologic cancer	4.21e-05	0.00104	CbGeAlD
Sunitinib—HIPK2—lymph node—hematologic cancer	4.2e-05	0.00104	CbGeAlD
Sunitinib—HIPK3—lymph node—hematologic cancer	4.2e-05	0.00104	CbGeAlD
Sunitinib—ALK—lymph node—hematologic cancer	4.2e-05	0.00104	CbGeAlD
Sunitinib—FGR—lung—hematologic cancer	4.19e-05	0.00104	CbGeAlD
Sunitinib—MAP3K7—testis—hematologic cancer	4.18e-05	0.00104	CbGeAlD
Sunitinib—AXL—lung—hematologic cancer	4.17e-05	0.00103	CbGeAlD
Sunitinib—EPHB6—blood—hematologic cancer	4.16e-05	0.00103	CbGeAlD
Sunitinib—TNK1—lymph node—hematologic cancer	4.16e-05	0.00103	CbGeAlD
Sunitinib—RIOK2—lymph node—hematologic cancer	4.16e-05	0.00103	CbGeAlD
Sunitinib—TBK1—testis—hematologic cancer	4.13e-05	0.00102	CbGeAlD
Sunitinib—MAP4K1—lymph node—hematologic cancer	4.11e-05	0.00102	CbGeAlD
Sunitinib—TYK2—testis—hematologic cancer	4.1e-05	0.00102	CbGeAlD
Sunitinib—IRAK1—testis—hematologic cancer	4.05e-05	0.001	CbGeAlD
Sunitinib—DAPK3—lymph node—hematologic cancer	4.03e-05	0.001	CbGeAlD
Sunitinib—YES1—blood—hematologic cancer	4.02e-05	0.000996	CbGeAlD
Sunitinib—SLK—lung—hematologic cancer	4.01e-05	0.000995	CbGeAlD
Sunitinib—CLK2—lymph node—hematologic cancer	4e-05	0.000991	CbGeAlD
Sunitinib—CSF1R—gonad—hematologic cancer	3.98e-05	0.000988	CbGeAlD
Sunitinib—STK10—blood—hematologic cancer	3.98e-05	0.000987	CbGeAlD
Sunitinib—MAP4K2—lymph node—hematologic cancer	3.98e-05	0.000987	CbGeAlD
Sunitinib—FGFR2—lung—hematologic cancer	3.98e-05	0.000987	CbGeAlD
Sunitinib—RPS6KB1—testis—hematologic cancer	3.97e-05	0.000986	CbGeAlD
Sunitinib—TAOK3—blood—hematologic cancer	3.97e-05	0.000984	CbGeAlD
Sunitinib—CYP3A4—Dexamethasone—hematologic cancer	3.96e-05	0.000156	CbGbCtD
Sunitinib—JAK2—lung—hematologic cancer	3.96e-05	0.000981	CbGeAlD
Sunitinib—FGR—testis—hematologic cancer	3.95e-05	0.00098	CbGeAlD
Sunitinib—RET—testis—hematologic cancer	3.95e-05	0.00098	CbGeAlD
Sunitinib—PDGFRA—blood—hematologic cancer	3.94e-05	0.000977	CbGeAlD
Sunitinib—AXL—testis—hematologic cancer	3.93e-05	0.000976	CbGeAlD
Sunitinib—STK3—lymph node—hematologic cancer	3.92e-05	0.000973	CbGeAlD
Sunitinib—CHEK2—Nilotinib—Imatinib—hematologic cancer	3.91e-05	0.0324	CbGdCrCtD
Sunitinib—FYN—lung—hematologic cancer	3.9e-05	0.000968	CbGeAlD
Sunitinib—YES1—bone marrow—hematologic cancer	3.89e-05	0.000964	CbGeAlD
Sunitinib—STK10—bone marrow—hematologic cancer	3.85e-05	0.000955	CbGeAlD
Sunitinib—TAOK3—bone marrow—hematologic cancer	3.84e-05	0.000952	CbGeAlD
Sunitinib—MAP3K3—lung—hematologic cancer	3.81e-05	0.000946	CbGeAlD
Sunitinib—MAP4K5—lung—hematologic cancer	3.81e-05	0.000946	CbGeAlD
Sunitinib—SLK—testis—hematologic cancer	3.79e-05	0.000939	CbGeAlD
Sunitinib—DYRK1A—lymph node—hematologic cancer	3.78e-05	0.000937	CbGeAlD
Sunitinib—FGFR2—testis—hematologic cancer	3.75e-05	0.000931	CbGeAlD
Sunitinib—JAK2—testis—hematologic cancer	3.73e-05	0.000926	CbGeAlD
Sunitinib—ABCC4—hematopoietic system—hematologic cancer	3.7e-05	0.000917	CbGeAlD
Sunitinib—MERTK—lymph node—hematologic cancer	3.69e-05	0.000915	CbGeAlD
Sunitinib—FLT1—lung—hematologic cancer	3.69e-05	0.000914	CbGeAlD
Sunitinib—FYN—testis—hematologic cancer	3.68e-05	0.000913	CbGeAlD
Sunitinib—EPHB6—lung—hematologic cancer	3.64e-05	0.000904	CbGeAlD
Sunitinib—MAP4K4—lymph node—hematologic cancer	3.62e-05	0.000898	CbGeAlD
Sunitinib—KIT—gonad—hematologic cancer	3.62e-05	0.000897	CbGeAlD
Sunitinib—DYRK1A—Topotecan—Irinotecan—hematologic cancer	3.6e-05	0.0299	CbGdCrCtD
Sunitinib—MAP3K3—testis—hematologic cancer	3.6e-05	0.000892	CbGeAlD
Sunitinib—MAP4K5—testis—hematologic cancer	3.6e-05	0.000892	CbGeAlD
Sunitinib—NUAK2—lymph node—hematologic cancer	3.6e-05	0.000892	CbGeAlD
Sunitinib—FLT3—lymph node—hematologic cancer	3.57e-05	0.000886	CbGeAlD
Sunitinib—MAP3K12—lymph node—hematologic cancer	3.57e-05	0.000886	CbGeAlD
Sunitinib—KDR—blood—hematologic cancer	3.56e-05	0.000882	CbGeAlD
Sunitinib—MAP2K5—blood—hematologic cancer	3.56e-05	0.000882	CbGeAlD
Sunitinib—PDGFRB—gonad—hematologic cancer	3.53e-05	0.000876	CbGeAlD
Sunitinib—YES1—lung—hematologic cancer	3.52e-05	0.000874	CbGeAlD
Sunitinib—RPS6KA3—lymph node—hematologic cancer	3.52e-05	0.000873	CbGeAlD
Sunitinib—MAP2K1—lymph node—hematologic cancer	3.5e-05	0.000868	CbGeAlD
Sunitinib—STK10—lung—hematologic cancer	3.49e-05	0.000866	CbGeAlD
Sunitinib—STK24—Teniposide—Etoposide—hematologic cancer	3.49e-05	0.0289	CbGdCrCtD
Sunitinib—FLT1—testis—hematologic cancer	3.48e-05	0.000863	CbGeAlD
Sunitinib—TAOK3—lung—hematologic cancer	3.48e-05	0.000862	CbGeAlD
Sunitinib—CSF1R—blood—hematologic cancer	3.47e-05	0.000861	CbGeAlD
Sunitinib—PDGFRA—lung—hematologic cancer	3.45e-05	0.000857	CbGeAlD
Sunitinib—CSNK1A1—lymph node—hematologic cancer	3.45e-05	0.000856	CbGeAlD
Sunitinib—KDR—bone marrow—hematologic cancer	3.44e-05	0.000853	CbGeAlD
Sunitinib—EPHB6—testis—hematologic cancer	3.44e-05	0.000853	CbGeAlD
Sunitinib—CLK1—lymph node—hematologic cancer	3.43e-05	0.000851	CbGeAlD
Sunitinib—CAMK2G—lymph node—hematologic cancer	3.37e-05	0.000835	CbGeAlD
Sunitinib—BMP2K—lymph node—hematologic cancer	3.37e-05	0.000835	CbGeAlD
Sunitinib—CSF1R—bone marrow—hematologic cancer	3.36e-05	0.000833	CbGeAlD
Sunitinib—LRRK2—lymph node—hematologic cancer	3.34e-05	0.000828	CbGeAlD
Sunitinib—YES1—testis—hematologic cancer	3.32e-05	0.000824	CbGeAlD
Sunitinib—STK10—testis—hematologic cancer	3.29e-05	0.000817	CbGeAlD
Sunitinib—PRKAA1—lymph node—hematologic cancer	3.29e-05	0.000816	CbGeAlD
Sunitinib—CYP3A4—Doxorubicin—hematologic cancer	3.29e-05	0.000129	CbGbCtD
Sunitinib—TAOK3—testis—hematologic cancer	3.28e-05	0.000814	CbGeAlD
Sunitinib—PDGFRA—testis—hematologic cancer	3.26e-05	0.000809	CbGeAlD
Sunitinib—PTK2B—lymph node—hematologic cancer	3.25e-05	0.000807	CbGeAlD
Sunitinib—FLT4—lymph node—hematologic cancer	3.24e-05	0.000804	CbGeAlD
Sunitinib—OXSR1—Menadione—Thalidomide—hematologic cancer	3.21e-05	0.0266	CbGdCrCtD
Sunitinib—FGFR1—lymph node—hematologic cancer	3.2e-05	0.000794	CbGeAlD
Sunitinib—CSNK1E—lymph node—hematologic cancer	3.2e-05	0.000794	CbGeAlD
Sunitinib—KIT—blood—hematologic cancer	3.15e-05	0.000781	CbGeAlD
Sunitinib—IRAK4—lymph node—hematologic cancer	3.15e-05	0.000781	CbGeAlD
Sunitinib—KDR—lung—hematologic cancer	3.12e-05	0.000773	CbGeAlD
Sunitinib—MAP2K5—lung—hematologic cancer	3.12e-05	0.000773	CbGeAlD
Sunitinib—ULK3—lymph node—hematologic cancer	3.08e-05	0.000764	CbGeAlD
Sunitinib—MAP2K2—lymph node—hematologic cancer	3.08e-05	0.000764	CbGeAlD
Sunitinib—PDGFRB—blood—hematologic cancer	3.08e-05	0.000763	CbGeAlD
Sunitinib—MAP3K2—lymph node—hematologic cancer	3.06e-05	0.000758	CbGeAlD
Sunitinib—KIT—bone marrow—hematologic cancer	3.05e-05	0.000756	CbGeAlD
Sunitinib—CSF1R—lung—hematologic cancer	3.04e-05	0.000754	CbGeAlD
Sunitinib—MAP3K7—lymph node—hematologic cancer	3.03e-05	0.000751	CbGeAlD
Sunitinib—CHEK2—Ponatinib—Nilotinib—hematologic cancer	3.02e-05	0.025	CbGdCrCtD
Sunitinib—TBK1—lymph node—hematologic cancer	2.99e-05	0.000743	CbGeAlD
Sunitinib—PDGFRB—bone marrow—hematologic cancer	2.98e-05	0.000739	CbGeAlD
Sunitinib—TYK2—lymph node—hematologic cancer	2.97e-05	0.000738	CbGeAlD
Sunitinib—KDR—testis—hematologic cancer	2.94e-05	0.000729	CbGeAlD
Sunitinib—MAP2K5—testis—hematologic cancer	2.94e-05	0.000729	CbGeAlD
Sunitinib—IRAK1—lymph node—hematologic cancer	2.94e-05	0.000728	CbGeAlD
Sunitinib—KCNH2—hematopoietic system—hematologic cancer	2.93e-05	0.000728	CbGeAlD
Sunitinib—RPS6KB1—lymph node—hematologic cancer	2.88e-05	0.000714	CbGeAlD
Sunitinib—CSF1R—testis—hematologic cancer	2.87e-05	0.000712	CbGeAlD
Sunitinib—RET—lymph node—hematologic cancer	2.86e-05	0.00071	CbGeAlD
Sunitinib—FGR—lymph node—hematologic cancer	2.86e-05	0.00071	CbGeAlD
Sunitinib—AXL—lymph node—hematologic cancer	2.85e-05	0.000707	CbGeAlD
Sunitinib—KIT—lung—hematologic cancer	2.76e-05	0.000685	CbGeAlD
Sunitinib—SLK—lymph node—hematologic cancer	2.74e-05	0.000681	CbGeAlD
Sunitinib—JAK2—lymph node—hematologic cancer	2.71e-05	0.000671	CbGeAlD
Sunitinib—PDGFRB—lung—hematologic cancer	2.7e-05	0.000669	CbGeAlD
Sunitinib—FYN—lymph node—hematologic cancer	2.67e-05	0.000662	CbGeAlD
Sunitinib—MAP4K5—lymph node—hematologic cancer	2.61e-05	0.000647	CbGeAlD
Sunitinib—MAP3K3—lymph node—hematologic cancer	2.61e-05	0.000647	CbGeAlD
Sunitinib—KIT—testis—hematologic cancer	2.61e-05	0.000646	CbGeAlD
Sunitinib—CAMK2G—Azacitidine—Pentostatin—hematologic cancer	2.55e-05	0.0211	CbGdCrCtD
Sunitinib—RPS6KA1—Menadione—Thalidomide—hematologic cancer	2.55e-05	0.0211	CbGdCrCtD
Sunitinib—PDGFRB—testis—hematologic cancer	2.55e-05	0.000631	CbGeAlD
Sunitinib—FLT1—lymph node—hematologic cancer	2.52e-05	0.000625	CbGeAlD
Sunitinib—EPHB6—lymph node—hematologic cancer	2.49e-05	0.000618	CbGeAlD
Sunitinib—PLK4—Topotecan—Irinotecan—hematologic cancer	2.46e-05	0.0204	CbGdCrCtD
Sunitinib—ABCC4—blood—hematologic cancer	2.45e-05	0.000608	CbGeAlD
Sunitinib—PLK4—Etoposide—Teniposide—hematologic cancer	2.45e-05	0.0203	CbGdCrCtD
Sunitinib—DYRK1A—Idarubicin—Daunorubicin—hematologic cancer	2.43e-05	0.0202	CbGdCrCtD
Sunitinib—DYRK1A—Doxorubicin—Daunorubicin—hematologic cancer	2.43e-05	0.0202	CbGdCrCtD
Sunitinib—DYRK1A—Epirubicin—Daunorubicin—hematologic cancer	2.43e-05	0.0202	CbGdCrCtD
Sunitinib—CYP3A5—hematopoietic system—hematologic cancer	2.42e-05	0.000601	CbGeAlD
Sunitinib—YES1—lymph node—hematologic cancer	2.41e-05	0.000597	CbGeAlD
Sunitinib—STK10—lymph node—hematologic cancer	2.39e-05	0.000592	CbGeAlD
Sunitinib—TAOK3—lymph node—hematologic cancer	2.38e-05	0.00059	CbGeAlD
Sunitinib—ABCC2—blood—hematologic cancer	2.37e-05	0.000588	CbGeAlD
Sunitinib—ABCC4—bone marrow—hematologic cancer	2.37e-05	0.000588	CbGeAlD
Sunitinib—PDGFRA—lymph node—hematologic cancer	2.36e-05	0.000586	CbGeAlD
Sunitinib—CHEK2—Ponatinib—Imatinib—hematologic cancer	2.29e-05	0.019	CbGdCrCtD
Sunitinib—CAMK2G—Azacitidine—Clofarabine—hematologic cancer	2.28e-05	0.0188	CbGdCrCtD
Sunitinib—ABCC4—lung—hematologic cancer	2.15e-05	0.000533	CbGeAlD
Sunitinib—CAMK2G—Azacitidine—Nelarabine—hematologic cancer	2.14e-05	0.0177	CbGdCrCtD
Sunitinib—MAP2K5—lymph node—hematologic cancer	2.13e-05	0.000529	CbGeAlD
Sunitinib—KDR—lymph node—hematologic cancer	2.13e-05	0.000529	CbGeAlD
Sunitinib—PRPF4—Idarubicin—Daunorubicin—hematologic cancer	2.1e-05	0.0174	CbGdCrCtD
Sunitinib—CSF1R—lymph node—hematologic cancer	2.08e-05	0.000516	CbGeAlD
Sunitinib—ABCC4—testis—hematologic cancer	2.03e-05	0.000503	CbGeAlD
Sunitinib—ABCC2—testis—hematologic cancer	1.96e-05	0.000487	CbGeAlD
Sunitinib—KCNH2—blood—hematologic cancer	1.94e-05	0.000482	CbGeAlD
Sunitinib—CHEK2—Vindesine—Vinorelbine—hematologic cancer	1.94e-05	0.0161	CbGdCrCtD
Sunitinib—KIT—lymph node—hematologic cancer	1.89e-05	0.000469	CbGeAlD
Sunitinib—KCNH2—bone marrow—hematologic cancer	1.88e-05	0.000467	CbGeAlD
Sunitinib—PDGFRB—lymph node—hematologic cancer	1.84e-05	0.000458	CbGeAlD
Sunitinib—DYRK1A—Daunorubicin—Idarubicin—hematologic cancer	1.84e-05	0.0153	CbGdCrCtD
Sunitinib—DYRK1A—Epirubicin—Idarubicin—hematologic cancer	1.84e-05	0.0153	CbGdCrCtD
Sunitinib—DYRK1A—Doxorubicin—Idarubicin—hematologic cancer	1.84e-05	0.0153	CbGdCrCtD
Sunitinib—CYP3A4—hematopoietic system—hematologic cancer	1.82e-05	0.000451	CbGeAlD
Sunitinib—ABCG2—blood—hematologic cancer	1.73e-05	0.000429	CbGeAlD
Sunitinib—ABCG2—bone marrow—hematologic cancer	1.67e-05	0.000415	CbGeAlD
Sunitinib—CAMK2G—Azacitidine—Fludarabine—hematologic cancer	1.67e-05	0.0138	CbGdCrCtD
Sunitinib—PLK4—Doxorubicin—Daunorubicin—hematologic cancer	1.66e-05	0.0138	CbGdCrCtD
Sunitinib—PLK4—Idarubicin—Daunorubicin—hematologic cancer	1.66e-05	0.0138	CbGdCrCtD
Sunitinib—PLK4—Epirubicin—Daunorubicin—hematologic cancer	1.66e-05	0.0138	CbGdCrCtD
Sunitinib—CHEK2—Podofilox—Teniposide—hematologic cancer	1.64e-05	0.0136	CbGdCrCtD
Sunitinib—KCNH2—testis—hematologic cancer	1.61e-05	0.000399	CbGeAlD
Sunitinib—CYP3A5—blood—hematologic cancer	1.61e-05	0.000398	CbGeAlD
Sunitinib—PRPF4—Daunorubicin—Idarubicin—hematologic cancer	1.59e-05	0.0132	CbGdCrCtD
Sunitinib—CAMK2G—Azacitidine—Cytarabine—hematologic cancer	1.58e-05	0.0131	CbGdCrCtD
Sunitinib—CAMK2G—Azacitidine—Gemcitabine—hematologic cancer	1.58e-05	0.0131	CbGdCrCtD
Sunitinib—CHEK2—Vindesine—Vincristine—hematologic cancer	1.55e-05	0.0128	CbGdCrCtD
Sunitinib—CHEK2—Vindesine—Vinblastine—hematologic cancer	1.55e-05	0.0128	CbGdCrCtD
Sunitinib—CAMK2G—Azacitidine—Cladribine—hematologic cancer	1.54e-05	0.0127	CbGdCrCtD
Sunitinib—ABCG2—lung—hematologic cancer	1.52e-05	0.000376	CbGeAlD
Sunitinib—ABCC4—lymph node—hematologic cancer	1.47e-05	0.000364	CbGeAlD
Sunitinib—CHEK2—Epirubicin—Daunorubicin—hematologic cancer	1.47e-05	0.0121	CbGdCrCtD
Sunitinib—CHEK2—Doxorubicin—Daunorubicin—hematologic cancer	1.47e-05	0.0121	CbGdCrCtD
Sunitinib—ABCG2—testis—hematologic cancer	1.43e-05	0.000355	CbGeAlD
Sunitinib—ABCC2—lymph node—hematologic cancer	1.42e-05	0.000353	CbGeAlD
Sunitinib—PLK4—Menadione—Thalidomide—hematologic cancer	1.41e-05	0.0117	CbGdCrCtD
Sunitinib—CYP3A5—lung—hematologic cancer	1.41e-05	0.000349	CbGeAlD
Sunitinib—RPS6KA1—Azacitidine—Pentostatin—hematologic cancer	1.31e-05	0.0108	CbGdCrCtD
Sunitinib—ABCB1—hematopoietic system—hematologic cancer	1.29e-05	0.000319	CbGeAlD
Sunitinib—PLK4—Epirubicin—Idarubicin—hematologic cancer	1.26e-05	0.0104	CbGdCrCtD
Sunitinib—PLK4—Doxorubicin—Idarubicin—hematologic cancer	1.26e-05	0.0104	CbGdCrCtD
Sunitinib—CYP3A4—blood—hematologic cancer	1.2e-05	0.000299	CbGeAlD
Sunitinib—KCNH2—lymph node—hematologic cancer	1.17e-05	0.000289	CbGeAlD
Sunitinib—RPS6KA1—Azacitidine—Clofarabine—hematologic cancer	1.16e-05	0.00965	CbGdCrCtD
Sunitinib—CHEK2—Epirubicin—Idarubicin—hematologic cancer	1.11e-05	0.0092	CbGdCrCtD
Sunitinib—CHEK2—Doxorubicin—Idarubicin—hematologic cancer	1.11e-05	0.0092	CbGdCrCtD
Sunitinib—PLK4—Teniposide—Etoposide—hematologic cancer	1.11e-05	0.00919	CbGdCrCtD
Sunitinib—RPS6KA1—Azacitidine—Nelarabine—hematologic cancer	1.1e-05	0.00907	CbGdCrCtD
Sunitinib—CHEK2—Vincristine—Vinorelbine—hematologic cancer	1.05e-05	0.00867	CbGdCrCtD
Sunitinib—ABCG2—lymph node—hematologic cancer	1.04e-05	0.000257	CbGeAlD
Sunitinib—TLK2—Progesterone—Prednisolone—hematologic cancer	1.03e-05	0.00856	CbGdCrCtD
Sunitinib—ABCB1—gonad—hematologic cancer	9.79e-06	0.000243	CbGeAlD
Sunitinib—CHEK2—Vinorelbine—Vinblastine—hematologic cancer	9.79e-06	0.00811	CbGdCrCtD
Sunitinib—CHEK2—Vinorelbine—Vincristine—hematologic cancer	9.79e-06	0.00811	CbGdCrCtD
Sunitinib—CHEK2—Teniposide—Etoposide—hematologic cancer	9.78e-06	0.0081	CbGdCrCtD
Sunitinib—CHEK2—Podofilox—Etoposide—hematologic cancer	9.78e-06	0.0081	CbGdCrCtD
Sunitinib—RPS6KA1—Azacitidine—Fludarabine—hematologic cancer	8.55e-06	0.00708	CbGdCrCtD
Sunitinib—ABCB1—blood—hematologic cancer	8.53e-06	0.000212	CbGeAlD
Sunitinib—DYRK1A—Idarubicin—Epirubicin—hematologic cancer	8.47e-06	0.00702	CbGdCrCtD
Sunitinib—DYRK1A—Daunorubicin—Epirubicin—hematologic cancer	8.47e-06	0.00702	CbGdCrCtD
Sunitinib—DYRK1A—Doxorubicin—Epirubicin—hematologic cancer	8.47e-06	0.00702	CbGdCrCtD
Sunitinib—CHEK2—Vinblastine—Vinorelbine—hematologic cancer	8.42e-06	0.00697	CbGdCrCtD
Sunitinib—CHEK2—Vincristine—Vinblastine—hematologic cancer	8.37e-06	0.00693	CbGdCrCtD
Sunitinib—ABCB1—bone marrow—hematologic cancer	8.25e-06	0.000205	CbGeAlD
Sunitinib—RPS6KA1—Azacitidine—Cytarabine—hematologic cancer	8.07e-06	0.00669	CbGdCrCtD
Sunitinib—RPS6KA1—Azacitidine—Gemcitabine—hematologic cancer	8.07e-06	0.00669	CbGdCrCtD
Sunitinib—RPS6KA1—Azacitidine—Cladribine—hematologic cancer	7.87e-06	0.00652	CbGdCrCtD
Sunitinib—DYRK1A—Daunorubicin—Doxorubicin—hematologic cancer	7.84e-06	0.00649	CbGdCrCtD
Sunitinib—DYRK1A—Epirubicin—Doxorubicin—hematologic cancer	7.84e-06	0.00649	CbGdCrCtD
Sunitinib—DYRK1A—Idarubicin—Doxorubicin—hematologic cancer	7.84e-06	0.00649	CbGdCrCtD
Sunitinib—ABCB1—lung—hematologic cancer	7.48e-06	0.000185	CbGeAlD
Sunitinib—PRPF4—Daunorubicin—Epirubicin—hematologic cancer	7.31e-06	0.00606	CbGdCrCtD
Sunitinib—PRPF4—Idarubicin—Epirubicin—hematologic cancer	7.31e-06	0.00606	CbGdCrCtD
Sunitinib—ABCB1—testis—hematologic cancer	7.05e-06	0.000175	CbGeAlD
Sunitinib—PRPF4—Idarubicin—Doxorubicin—hematologic cancer	6.77e-06	0.0056	CbGdCrCtD
Sunitinib—PRPF4—Daunorubicin—Doxorubicin—hematologic cancer	6.77e-06	0.0056	CbGdCrCtD
Sunitinib—CHEK2—Vinblastine—Vincristine—hematologic cancer	6.73e-06	0.00557	CbGdCrCtD
Sunitinib—PLK4—Idarubicin—Epirubicin—hematologic cancer	5.79e-06	0.00479	CbGdCrCtD
Sunitinib—PLK4—Doxorubicin—Epirubicin—hematologic cancer	5.79e-06	0.00479	CbGdCrCtD
Sunitinib—PLK4—Idarubicin—Doxorubicin—hematologic cancer	5.35e-06	0.00444	CbGdCrCtD
Sunitinib—PLK4—Epirubicin—Doxorubicin—hematologic cancer	5.35e-06	0.00444	CbGdCrCtD
Sunitinib—ABCB1—lymph node—hematologic cancer	5.11e-06	0.000127	CbGeAlD
Sunitinib—CHEK2—Doxorubicin—Epirubicin—hematologic cancer	5.1e-06	0.00422	CbGdCrCtD
Sunitinib—CHEK2—Epirubicin—Doxorubicin—hematologic cancer	4.72e-06	0.00391	CbGdCrCtD
Sunitinib—CSNK1E—Danazol—Prednisone—hematologic cancer	3.33e-06	0.00276	CbGdCrCtD
Sunitinib—Headache—Gemcitabine—hematologic cancer	3.18e-06	4.47e-05	CcSEcCtD
Sunitinib—Nausea—Vincristine—hematologic cancer	3.18e-06	4.47e-05	CcSEcCtD
Sunitinib—Flushing—Epirubicin—hematologic cancer	3.17e-06	4.46e-05	CcSEcCtD
Sunitinib—Cardiac disorder—Epirubicin—hematologic cancer	3.17e-06	4.46e-05	CcSEcCtD
Sunitinib—Hepatitis—Doxorubicin—hematologic cancer	3.16e-06	4.45e-05	CcSEcCtD
Sunitinib—Haemorrhage—Doxorubicin—hematologic cancer	3.16e-06	4.45e-05	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisolone—hematologic cancer	3.15e-06	4.43e-05	CcSEcCtD
Sunitinib—Hypoaesthesia—Doxorubicin—hematologic cancer	3.15e-06	4.42e-05	CcSEcCtD
Sunitinib—Dyspepsia—Dexamethasone—hematologic cancer	3.14e-06	4.41e-05	CcSEcCtD
Sunitinib—Dyspepsia—Betamethasone—hematologic cancer	3.14e-06	4.41e-05	CcSEcCtD
Sunitinib—Urinary tract disorder—Doxorubicin—hematologic cancer	3.12e-06	4.39e-05	CcSEcCtD
Sunitinib—Oedema peripheral—Doxorubicin—hematologic cancer	3.12e-06	4.38e-05	CcSEcCtD
Sunitinib—Dysgeusia—Methotrexate—hematologic cancer	3.11e-06	4.38e-05	CcSEcCtD
Sunitinib—Asthenia—Etoposide—hematologic cancer	3.11e-06	4.37e-05	CcSEcCtD
Sunitinib—Connective tissue disorder—Doxorubicin—hematologic cancer	3.11e-06	4.37e-05	CcSEcCtD
Sunitinib—Body temperature increased—Triamcinolone—hematologic cancer	3.11e-06	4.37e-05	CcSEcCtD
Sunitinib—Oedema—Prednisone—hematologic cancer	3.11e-06	4.37e-05	CcSEcCtD
Sunitinib—Angiopathy—Epirubicin—hematologic cancer	3.1e-06	4.36e-05	CcSEcCtD
Sunitinib—Urethral disorder—Doxorubicin—hematologic cancer	3.1e-06	4.36e-05	CcSEcCtD
Sunitinib—Decreased appetite—Dexamethasone—hematologic cancer	3.1e-06	4.36e-05	CcSEcCtD
Sunitinib—Decreased appetite—Betamethasone—hematologic cancer	3.1e-06	4.36e-05	CcSEcCtD
Sunitinib—Nausea—Mitoxantrone—hematologic cancer	3.09e-06	4.35e-05	CcSEcCtD
Sunitinib—Nausea—Irinotecan—hematologic cancer	3.09e-06	4.35e-05	CcSEcCtD
Sunitinib—Immune system disorder—Epirubicin—hematologic cancer	3.09e-06	4.34e-05	CcSEcCtD
Sunitinib—Infection—Prednisone—hematologic cancer	3.09e-06	4.34e-05	CcSEcCtD
Sunitinib—Mediastinal disorder—Epirubicin—hematologic cancer	3.08e-06	4.33e-05	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.08e-06	4.33e-05	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.08e-06	4.33e-05	CcSEcCtD
Sunitinib—Back pain—Methotrexate—hematologic cancer	3.08e-06	4.32e-05	CcSEcCtD
Sunitinib—Fatigue—Betamethasone—hematologic cancer	3.08e-06	4.32e-05	CcSEcCtD
Sunitinib—Fatigue—Dexamethasone—hematologic cancer	3.08e-06	4.32e-05	CcSEcCtD
Sunitinib—Chills—Epirubicin—hematologic cancer	3.07e-06	4.31e-05	CcSEcCtD
Sunitinib—Pruritus—Etoposide—hematologic cancer	3.07e-06	4.31e-05	CcSEcCtD
Sunitinib—Shock—Prednisone—hematologic cancer	3.06e-06	4.3e-05	CcSEcCtD
Sunitinib—Arrhythmia—Epirubicin—hematologic cancer	3.05e-06	4.29e-05	CcSEcCtD
Sunitinib—Pain—Betamethasone—hematologic cancer	3.05e-06	4.29e-05	CcSEcCtD
Sunitinib—Pain—Dexamethasone—hematologic cancer	3.05e-06	4.29e-05	CcSEcCtD
Sunitinib—Nervous system disorder—Prednisone—hematologic cancer	3.05e-06	4.28e-05	CcSEcCtD
Sunitinib—Alopecia—Epirubicin—hematologic cancer	3.02e-06	4.25e-05	CcSEcCtD
Sunitinib—Skin disorder—Prednisone—hematologic cancer	3.02e-06	4.24e-05	CcSEcCtD
Sunitinib—Nausea—Gemcitabine—hematologic cancer	3.01e-06	4.24e-05	CcSEcCtD
Sunitinib—Vomiting—Cisplatin—hematologic cancer	3.01e-06	4.23e-05	CcSEcCtD
Sunitinib—Mental disorder—Epirubicin—hematologic cancer	3e-06	4.21e-05	CcSEcCtD
Sunitinib—Erythema multiforme—Doxorubicin—hematologic cancer	2.99e-06	4.2e-05	CcSEcCtD
Sunitinib—Rash—Cisplatin—hematologic cancer	2.98e-06	4.19e-05	CcSEcCtD
Sunitinib—Dermatitis—Cisplatin—hematologic cancer	2.98e-06	4.19e-05	CcSEcCtD
Sunitinib—Malnutrition—Epirubicin—hematologic cancer	2.98e-06	4.18e-05	CcSEcCtD
Sunitinib—Erythema—Epirubicin—hematologic cancer	2.98e-06	4.18e-05	CcSEcCtD
Sunitinib—Diarrhoea—Etoposide—hematologic cancer	2.97e-06	4.17e-05	CcSEcCtD
Sunitinib—Anorexia—Prednisone—hematologic cancer	2.96e-06	4.16e-05	CcSEcCtD
Sunitinib—Eye disorder—Doxorubicin—hematologic cancer	2.96e-06	4.16e-05	CcSEcCtD
Sunitinib—Anaemia—Methotrexate—hematologic cancer	2.94e-06	4.13e-05	CcSEcCtD
Sunitinib—Flushing—Doxorubicin—hematologic cancer	2.94e-06	4.13e-05	CcSEcCtD
Sunitinib—Cardiac disorder—Doxorubicin—hematologic cancer	2.94e-06	4.13e-05	CcSEcCtD
Sunitinib—Flatulence—Epirubicin—hematologic cancer	2.93e-06	4.12e-05	CcSEcCtD
Sunitinib—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.92e-06	4.1e-05	CcSEcCtD
Sunitinib—Gastrointestinal pain—Betamethasone—hematologic cancer	2.92e-06	4.1e-05	CcSEcCtD
Sunitinib—Dysgeusia—Epirubicin—hematologic cancer	2.92e-06	4.1e-05	CcSEcCtD
Sunitinib—Hypersensitivity—Triamcinolone—hematologic cancer	2.9e-06	4.07e-05	CcSEcCtD
Sunitinib—Back pain—Epirubicin—hematologic cancer	2.88e-06	4.05e-05	CcSEcCtD
Sunitinib—Angiopathy—Doxorubicin—hematologic cancer	2.87e-06	4.03e-05	CcSEcCtD
Sunitinib—Dizziness—Etoposide—hematologic cancer	2.87e-06	4.03e-05	CcSEcCtD
Sunitinib—Muscle spasms—Epirubicin—hematologic cancer	2.86e-06	4.02e-05	CcSEcCtD
Sunitinib—Immune system disorder—Doxorubicin—hematologic cancer	2.86e-06	4.02e-05	CcSEcCtD
Sunitinib—Mediastinal disorder—Doxorubicin—hematologic cancer	2.85e-06	4.01e-05	CcSEcCtD
Sunitinib—Leukopenia—Methotrexate—hematologic cancer	2.85e-06	4e-05	CcSEcCtD
Sunitinib—Chills—Doxorubicin—hematologic cancer	2.84e-06	3.99e-05	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.83e-06	3.98e-05	CcSEcCtD
Sunitinib—Dizziness—Prednisolone—hematologic cancer	2.83e-06	3.97e-05	CcSEcCtD
Sunitinib—Arrhythmia—Doxorubicin—hematologic cancer	2.83e-06	3.97e-05	CcSEcCtD
Sunitinib—Asthenia—Triamcinolone—hematologic cancer	2.82e-06	3.96e-05	CcSEcCtD
Sunitinib—Body temperature increased—Betamethasone—hematologic cancer	2.82e-06	3.96e-05	CcSEcCtD
Sunitinib—Body temperature increased—Dexamethasone—hematologic cancer	2.82e-06	3.96e-05	CcSEcCtD
Sunitinib—Abdominal pain—Betamethasone—hematologic cancer	2.82e-06	3.96e-05	CcSEcCtD
Sunitinib—Abdominal pain—Dexamethasone—hematologic cancer	2.82e-06	3.96e-05	CcSEcCtD
Sunitinib—Nausea—Cisplatin—hematologic cancer	2.81e-06	3.95e-05	CcSEcCtD
Sunitinib—Insomnia—Prednisone—hematologic cancer	2.81e-06	3.95e-05	CcSEcCtD
Sunitinib—Alopecia—Doxorubicin—hematologic cancer	2.8e-06	3.93e-05	CcSEcCtD
Sunitinib—Paraesthesia—Prednisone—hematologic cancer	2.79e-06	3.92e-05	CcSEcCtD
Sunitinib—Pruritus—Triamcinolone—hematologic cancer	2.78e-06	3.91e-05	CcSEcCtD
Sunitinib—Cough—Methotrexate—hematologic cancer	2.78e-06	3.9e-05	CcSEcCtD
Sunitinib—Mental disorder—Doxorubicin—hematologic cancer	2.77e-06	3.9e-05	CcSEcCtD
Sunitinib—Convulsion—Methotrexate—hematologic cancer	2.76e-06	3.87e-05	CcSEcCtD
Sunitinib—Vomiting—Etoposide—hematologic cancer	2.76e-06	3.87e-05	CcSEcCtD
Sunitinib—Malnutrition—Doxorubicin—hematologic cancer	2.75e-06	3.87e-05	CcSEcCtD
Sunitinib—Erythema—Doxorubicin—hematologic cancer	2.75e-06	3.87e-05	CcSEcCtD
Sunitinib—Anaemia—Epirubicin—hematologic cancer	2.75e-06	3.87e-05	CcSEcCtD
Sunitinib—Dyspepsia—Prednisone—hematologic cancer	2.73e-06	3.84e-05	CcSEcCtD
Sunitinib—Rash—Etoposide—hematologic cancer	2.73e-06	3.84e-05	CcSEcCtD
Sunitinib—Dermatitis—Etoposide—hematologic cancer	2.73e-06	3.84e-05	CcSEcCtD
Sunitinib—Headache—Etoposide—hematologic cancer	2.72e-06	3.82e-05	CcSEcCtD
Sunitinib—Flatulence—Doxorubicin—hematologic cancer	2.71e-06	3.81e-05	CcSEcCtD
Sunitinib—Chest pain—Methotrexate—hematologic cancer	2.71e-06	3.81e-05	CcSEcCtD
Sunitinib—Arthralgia—Methotrexate—hematologic cancer	2.71e-06	3.81e-05	CcSEcCtD
Sunitinib—Myalgia—Methotrexate—hematologic cancer	2.71e-06	3.81e-05	CcSEcCtD
Sunitinib—Decreased appetite—Prednisone—hematologic cancer	2.7e-06	3.79e-05	CcSEcCtD
Sunitinib—Dysgeusia—Doxorubicin—hematologic cancer	2.7e-06	3.79e-05	CcSEcCtD
Sunitinib—Rash—Prednisolone—hematologic cancer	2.7e-06	3.79e-05	CcSEcCtD
Sunitinib—Dermatitis—Prednisolone—hematologic cancer	2.69e-06	3.78e-05	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.69e-06	3.78e-05	CcSEcCtD
Sunitinib—Fatigue—Prednisone—hematologic cancer	2.68e-06	3.76e-05	CcSEcCtD
Sunitinib—Headache—Prednisolone—hematologic cancer	2.68e-06	3.76e-05	CcSEcCtD
Sunitinib—Leukopenia—Epirubicin—hematologic cancer	2.66e-06	3.74e-05	CcSEcCtD
Sunitinib—Back pain—Doxorubicin—hematologic cancer	2.66e-06	3.74e-05	CcSEcCtD
Sunitinib—Constipation—Prednisone—hematologic cancer	2.66e-06	3.73e-05	CcSEcCtD
Sunitinib—Muscle spasms—Doxorubicin—hematologic cancer	2.65e-06	3.72e-05	CcSEcCtD
Sunitinib—Dizziness—Triamcinolone—hematologic cancer	2.6e-06	3.65e-05	CcSEcCtD
Sunitinib—Cough—Epirubicin—hematologic cancer	2.6e-06	3.65e-05	CcSEcCtD
Sunitinib—Convulsion—Epirubicin—hematologic cancer	2.58e-06	3.62e-05	CcSEcCtD
Sunitinib—Infection—Methotrexate—hematologic cancer	2.58e-06	3.62e-05	CcSEcCtD
Sunitinib—Nausea—Etoposide—hematologic cancer	2.57e-06	3.62e-05	CcSEcCtD
Sunitinib—Hypertension—Epirubicin—hematologic cancer	2.57e-06	3.61e-05	CcSEcCtD
Sunitinib—Asthenia—Dexamethasone—hematologic cancer	2.56e-06	3.6e-05	CcSEcCtD
Sunitinib—Asthenia—Betamethasone—hematologic cancer	2.56e-06	3.6e-05	CcSEcCtD
Sunitinib—Nervous system disorder—Methotrexate—hematologic cancer	2.55e-06	3.58e-05	CcSEcCtD
Sunitinib—Anaemia—Doxorubicin—hematologic cancer	2.55e-06	3.58e-05	CcSEcCtD
Sunitinib—Thrombocytopenia—Methotrexate—hematologic cancer	2.54e-06	3.57e-05	CcSEcCtD
Sunitinib—Gastrointestinal pain—Prednisone—hematologic cancer	2.54e-06	3.57e-05	CcSEcCtD
Sunitinib—Nausea—Prednisolone—hematologic cancer	2.54e-06	3.57e-05	CcSEcCtD
Sunitinib—Arthralgia—Epirubicin—hematologic cancer	2.53e-06	3.56e-05	CcSEcCtD
Sunitinib—Myalgia—Epirubicin—hematologic cancer	2.53e-06	3.56e-05	CcSEcCtD
Sunitinib—Chest pain—Epirubicin—hematologic cancer	2.53e-06	3.56e-05	CcSEcCtD
Sunitinib—Pruritus—Dexamethasone—hematologic cancer	2.52e-06	3.55e-05	CcSEcCtD
Sunitinib—Pruritus—Betamethasone—hematologic cancer	2.52e-06	3.55e-05	CcSEcCtD
Sunitinib—Skin disorder—Methotrexate—hematologic cancer	2.52e-06	3.54e-05	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.52e-06	3.54e-05	CcSEcCtD
Sunitinib—Vomiting—Triamcinolone—hematologic cancer	2.5e-06	3.51e-05	CcSEcCtD
Sunitinib—Rash—Triamcinolone—hematologic cancer	2.48e-06	3.48e-05	CcSEcCtD
Sunitinib—Dry mouth—Epirubicin—hematologic cancer	2.48e-06	3.48e-05	CcSEcCtD
Sunitinib—Dermatitis—Triamcinolone—hematologic cancer	2.48e-06	3.48e-05	CcSEcCtD
Sunitinib—Anorexia—Methotrexate—hematologic cancer	2.47e-06	3.48e-05	CcSEcCtD
Sunitinib—Leukopenia—Doxorubicin—hematologic cancer	2.47e-06	3.46e-05	CcSEcCtD
Sunitinib—Headache—Triamcinolone—hematologic cancer	2.46e-06	3.46e-05	CcSEcCtD
Sunitinib—Abdominal pain—Prednisone—hematologic cancer	2.46e-06	3.45e-05	CcSEcCtD
Sunitinib—Body temperature increased—Prednisone—hematologic cancer	2.46e-06	3.45e-05	CcSEcCtD
Sunitinib—Diarrhoea—Betamethasone—hematologic cancer	2.44e-06	3.43e-05	CcSEcCtD
Sunitinib—Diarrhoea—Dexamethasone—hematologic cancer	2.44e-06	3.43e-05	CcSEcCtD
Sunitinib—Oedema—Epirubicin—hematologic cancer	2.43e-06	3.41e-05	CcSEcCtD
Sunitinib—Infection—Epirubicin—hematologic cancer	2.41e-06	3.39e-05	CcSEcCtD
Sunitinib—Cough—Doxorubicin—hematologic cancer	2.4e-06	3.38e-05	CcSEcCtD
Sunitinib—Shock—Epirubicin—hematologic cancer	2.39e-06	3.36e-05	CcSEcCtD
Sunitinib—Convulsion—Doxorubicin—hematologic cancer	2.39e-06	3.35e-05	CcSEcCtD
Sunitinib—Nervous system disorder—Epirubicin—hematologic cancer	2.38e-06	3.35e-05	CcSEcCtD
Sunitinib—Thrombocytopenia—Epirubicin—hematologic cancer	2.38e-06	3.34e-05	CcSEcCtD
Sunitinib—Hypertension—Doxorubicin—hematologic cancer	2.38e-06	3.34e-05	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.37e-06	3.32e-05	CcSEcCtD
Sunitinib—Skin disorder—Epirubicin—hematologic cancer	2.36e-06	3.32e-05	CcSEcCtD
Sunitinib—Dizziness—Betamethasone—hematologic cancer	2.36e-06	3.31e-05	CcSEcCtD
Sunitinib—Dizziness—Dexamethasone—hematologic cancer	2.36e-06	3.31e-05	CcSEcCtD
Sunitinib—Insomnia—Methotrexate—hematologic cancer	2.35e-06	3.3e-05	CcSEcCtD
Sunitinib—Arthralgia—Doxorubicin—hematologic cancer	2.34e-06	3.3e-05	CcSEcCtD
Sunitinib—Chest pain—Doxorubicin—hematologic cancer	2.34e-06	3.3e-05	CcSEcCtD
Sunitinib—Myalgia—Doxorubicin—hematologic cancer	2.34e-06	3.3e-05	CcSEcCtD
Sunitinib—Nausea—Triamcinolone—hematologic cancer	2.34e-06	3.28e-05	CcSEcCtD
Sunitinib—Paraesthesia—Methotrexate—hematologic cancer	2.33e-06	3.28e-05	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.33e-06	3.27e-05	CcSEcCtD
Sunitinib—Anorexia—Epirubicin—hematologic cancer	2.32e-06	3.25e-05	CcSEcCtD
Sunitinib—Dyspnoea—Methotrexate—hematologic cancer	2.31e-06	3.25e-05	CcSEcCtD
Sunitinib—Dry mouth—Doxorubicin—hematologic cancer	2.29e-06	3.22e-05	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Dexamethasone—hematologic cancer	2.29e-06	0.0019	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Betamethasone—hematologic cancer	2.29e-06	0.0019	CbGdCrCtD
Sunitinib—Hypersensitivity—Prednisone—hematologic cancer	2.29e-06	3.22e-05	CcSEcCtD
Sunitinib—Dyspepsia—Methotrexate—hematologic cancer	2.29e-06	3.21e-05	CcSEcCtD
Sunitinib—Vomiting—Dexamethasone—hematologic cancer	2.27e-06	3.19e-05	CcSEcCtD
Sunitinib—Vomiting—Betamethasone—hematologic cancer	2.27e-06	3.19e-05	CcSEcCtD
Sunitinib—Decreased appetite—Methotrexate—hematologic cancer	2.26e-06	3.17e-05	CcSEcCtD
Sunitinib—Rash—Betamethasone—hematologic cancer	2.25e-06	3.16e-05	CcSEcCtD
Sunitinib—Rash—Dexamethasone—hematologic cancer	2.25e-06	3.16e-05	CcSEcCtD
Sunitinib—Oedema—Doxorubicin—hematologic cancer	2.25e-06	3.16e-05	CcSEcCtD
Sunitinib—Dermatitis—Betamethasone—hematologic cancer	2.25e-06	3.16e-05	CcSEcCtD
Sunitinib—Dermatitis—Dexamethasone—hematologic cancer	2.25e-06	3.16e-05	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.24e-06	3.15e-05	CcSEcCtD
Sunitinib—Fatigue—Methotrexate—hematologic cancer	2.24e-06	3.15e-05	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Triamcinolone—hematologic cancer	2.24e-06	0.00185	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Triamcinolone—hematologic cancer	2.24e-06	0.00185	CbGdCrCtD
Sunitinib—Headache—Betamethasone—hematologic cancer	2.23e-06	3.14e-05	CcSEcCtD
Sunitinib—Headache—Dexamethasone—hematologic cancer	2.23e-06	3.14e-05	CcSEcCtD
Sunitinib—Infection—Doxorubicin—hematologic cancer	2.23e-06	3.14e-05	CcSEcCtD
Sunitinib—Asthenia—Prednisone—hematologic cancer	2.23e-06	3.13e-05	CcSEcCtD
Sunitinib—Pain—Methotrexate—hematologic cancer	2.22e-06	3.12e-05	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.21e-06	3.11e-05	CcSEcCtD
Sunitinib—Shock—Doxorubicin—hematologic cancer	2.21e-06	3.11e-05	CcSEcCtD
Sunitinib—Nervous system disorder—Doxorubicin—hematologic cancer	2.2e-06	3.1e-05	CcSEcCtD
Sunitinib—Thrombocytopenia—Doxorubicin—hematologic cancer	2.2e-06	3.09e-05	CcSEcCtD
Sunitinib—Pruritus—Prednisone—hematologic cancer	2.2e-06	3.09e-05	CcSEcCtD
Sunitinib—Insomnia—Epirubicin—hematologic cancer	2.2e-06	3.09e-05	CcSEcCtD
Sunitinib—Skin disorder—Doxorubicin—hematologic cancer	2.18e-06	3.07e-05	CcSEcCtD
Sunitinib—Paraesthesia—Epirubicin—hematologic cancer	2.18e-06	3.07e-05	CcSEcCtD
Sunitinib—Dyspnoea—Epirubicin—hematologic cancer	2.17e-06	3.04e-05	CcSEcCtD
Sunitinib—Anorexia—Doxorubicin—hematologic cancer	2.14e-06	3.01e-05	CcSEcCtD
Sunitinib—Dyspepsia—Epirubicin—hematologic cancer	2.14e-06	3.01e-05	CcSEcCtD
Sunitinib—Diarrhoea—Prednisone—hematologic cancer	2.13e-06	2.99e-05	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Prednisone—hematologic cancer	2.12e-06	0.00176	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisone—hematologic cancer	2.12e-06	0.00176	CbGdCrCtD
Sunitinib—Gastrointestinal pain—Methotrexate—hematologic cancer	2.12e-06	2.98e-05	CcSEcCtD
Sunitinib—Nausea—Dexamethasone—hematologic cancer	2.12e-06	2.98e-05	CcSEcCtD
Sunitinib—Nausea—Betamethasone—hematologic cancer	2.12e-06	2.98e-05	CcSEcCtD
Sunitinib—Decreased appetite—Epirubicin—hematologic cancer	2.11e-06	2.97e-05	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.1e-06	2.95e-05	CcSEcCtD
Sunitinib—Fatigue—Epirubicin—hematologic cancer	2.09e-06	2.94e-05	CcSEcCtD
Sunitinib—Pain—Epirubicin—hematologic cancer	2.08e-06	2.92e-05	CcSEcCtD
Sunitinib—Constipation—Epirubicin—hematologic cancer	2.08e-06	2.92e-05	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Prednisolone—hematologic cancer	2.07e-06	0.00172	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisolone—hematologic cancer	2.07e-06	0.00172	CbGdCrCtD
Sunitinib—Dizziness—Prednisone—hematologic cancer	2.05e-06	2.89e-05	CcSEcCtD
Sunitinib—Body temperature increased—Methotrexate—hematologic cancer	2.05e-06	2.88e-05	CcSEcCtD
Sunitinib—Abdominal pain—Methotrexate—hematologic cancer	2.05e-06	2.88e-05	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.05e-06	2.88e-05	CcSEcCtD
Sunitinib—Insomnia—Doxorubicin—hematologic cancer	2.03e-06	2.86e-05	CcSEcCtD
Sunitinib—Paraesthesia—Doxorubicin—hematologic cancer	2.02e-06	2.84e-05	CcSEcCtD
Sunitinib—Dyspnoea—Doxorubicin—hematologic cancer	2e-06	2.82e-05	CcSEcCtD
Sunitinib—Procainamide—SLC22A1—hematologic cancer	2e-06	1	CrCbGaD
Sunitinib—Gastrointestinal pain—Epirubicin—hematologic cancer	1.99e-06	2.79e-05	CcSEcCtD
Sunitinib—Dyspepsia—Doxorubicin—hematologic cancer	1.98e-06	2.78e-05	CcSEcCtD
Sunitinib—Vomiting—Prednisone—hematologic cancer	1.98e-06	2.78e-05	CcSEcCtD
Sunitinib—Rash—Prednisone—hematologic cancer	1.96e-06	2.75e-05	CcSEcCtD
Sunitinib—Dermatitis—Prednisone—hematologic cancer	1.96e-06	2.75e-05	CcSEcCtD
Sunitinib—Decreased appetite—Doxorubicin—hematologic cancer	1.95e-06	2.75e-05	CcSEcCtD
Sunitinib—Headache—Prednisone—hematologic cancer	1.95e-06	2.73e-05	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.94e-06	2.73e-05	CcSEcCtD
Sunitinib—Fatigue—Doxorubicin—hematologic cancer	1.94e-06	2.72e-05	CcSEcCtD
Sunitinib—Pain—Doxorubicin—hematologic cancer	1.92e-06	2.7e-05	CcSEcCtD
Sunitinib—Constipation—Doxorubicin—hematologic cancer	1.92e-06	2.7e-05	CcSEcCtD
Sunitinib—Body temperature increased—Epirubicin—hematologic cancer	1.92e-06	2.7e-05	CcSEcCtD
Sunitinib—Abdominal pain—Epirubicin—hematologic cancer	1.92e-06	2.7e-05	CcSEcCtD
Sunitinib—Hypersensitivity—Methotrexate—hematologic cancer	1.91e-06	2.69e-05	CcSEcCtD
Sunitinib—Asthenia—Methotrexate—hematologic cancer	1.86e-06	2.62e-05	CcSEcCtD
Sunitinib—Nausea—Prednisone—hematologic cancer	1.85e-06	2.59e-05	CcSEcCtD
Sunitinib—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.84e-06	2.58e-05	CcSEcCtD
Sunitinib—Pruritus—Methotrexate—hematologic cancer	1.84e-06	2.58e-05	CcSEcCtD
Sunitinib—Hypersensitivity—Epirubicin—hematologic cancer	1.79e-06	2.52e-05	CcSEcCtD
Sunitinib—Abdominal pain—Doxorubicin—hematologic cancer	1.78e-06	2.5e-05	CcSEcCtD
Sunitinib—Body temperature increased—Doxorubicin—hematologic cancer	1.78e-06	2.5e-05	CcSEcCtD
Sunitinib—Diarrhoea—Methotrexate—hematologic cancer	1.78e-06	2.5e-05	CcSEcCtD
Sunitinib—Asthenia—Epirubicin—hematologic cancer	1.74e-06	2.45e-05	CcSEcCtD
Sunitinib—Pruritus—Epirubicin—hematologic cancer	1.72e-06	2.42e-05	CcSEcCtD
Sunitinib—Dizziness—Methotrexate—hematologic cancer	1.72e-06	2.41e-05	CcSEcCtD
Sunitinib—CHEK2—Danazol—Prednisone—hematologic cancer	1.7e-06	0.00141	CbGdCrCtD
Sunitinib—Diarrhoea—Epirubicin—hematologic cancer	1.66e-06	2.34e-05	CcSEcCtD
Sunitinib—Hypersensitivity—Doxorubicin—hematologic cancer	1.66e-06	2.33e-05	CcSEcCtD
Sunitinib—Vomiting—Methotrexate—hematologic cancer	1.65e-06	2.32e-05	CcSEcCtD
Sunitinib—Rash—Methotrexate—hematologic cancer	1.64e-06	2.3e-05	CcSEcCtD
Sunitinib—Dermatitis—Methotrexate—hematologic cancer	1.64e-06	2.3e-05	CcSEcCtD
Sunitinib—Headache—Methotrexate—hematologic cancer	1.63e-06	2.29e-05	CcSEcCtD
Sunitinib—Asthenia—Doxorubicin—hematologic cancer	1.61e-06	2.27e-05	CcSEcCtD
Sunitinib—Dizziness—Epirubicin—hematologic cancer	1.61e-06	2.26e-05	CcSEcCtD
Sunitinib—Pruritus—Doxorubicin—hematologic cancer	1.59e-06	2.24e-05	CcSEcCtD
Sunitinib—Vomiting—Epirubicin—hematologic cancer	1.54e-06	2.17e-05	CcSEcCtD
Sunitinib—Nausea—Methotrexate—hematologic cancer	1.54e-06	2.17e-05	CcSEcCtD
Sunitinib—Diarrhoea—Doxorubicin—hematologic cancer	1.54e-06	2.16e-05	CcSEcCtD
Sunitinib—Rash—Epirubicin—hematologic cancer	1.53e-06	2.15e-05	CcSEcCtD
Sunitinib—Dermatitis—Epirubicin—hematologic cancer	1.53e-06	2.15e-05	CcSEcCtD
Sunitinib—Headache—Epirubicin—hematologic cancer	1.52e-06	2.14e-05	CcSEcCtD
Sunitinib—Dizziness—Doxorubicin—hematologic cancer	1.49e-06	2.09e-05	CcSEcCtD
Sunitinib—Nausea—Epirubicin—hematologic cancer	1.44e-06	2.03e-05	CcSEcCtD
Sunitinib—Vomiting—Doxorubicin—hematologic cancer	1.43e-06	2.01e-05	CcSEcCtD
Sunitinib—Rash—Doxorubicin—hematologic cancer	1.42e-06	1.99e-05	CcSEcCtD
Sunitinib—Dermatitis—Doxorubicin—hematologic cancer	1.42e-06	1.99e-05	CcSEcCtD
Sunitinib—Headache—Doxorubicin—hematologic cancer	1.41e-06	1.98e-05	CcSEcCtD
Sunitinib—Nausea—Doxorubicin—hematologic cancer	1.34e-06	1.88e-05	CcSEcCtD
Sunitinib—MAP2K1—Signaling Pathways—CCND1—hematologic cancer	5.07e-08	7.11e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NRAS—hematologic cancer	5.06e-08	7.1e-07	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—hematologic cancer	5.06e-08	7.1e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—STAT3—hematologic cancer	5.06e-08	7.1e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MYC—hematologic cancer	5.06e-08	7.1e-07	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—hematologic cancer	5.06e-08	7.1e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—JUN—hematologic cancer	5.05e-08	7.09e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NRAS—hematologic cancer	5.05e-08	7.08e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—hematologic cancer	5.05e-08	7.08e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—hematologic cancer	5.05e-08	7.08e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—hematologic cancer	5.05e-08	7.08e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—hematologic cancer	5.05e-08	7.08e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.04e-08	7.07e-07	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—HRAS—hematologic cancer	5.03e-08	7.06e-07	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—hematologic cancer	5.02e-08	7.04e-07	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—hematologic cancer	5.01e-08	7.03e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK8—hematologic cancer	4.99e-08	7e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EP300—hematologic cancer	4.98e-08	6.99e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CASP3—hematologic cancer	4.97e-08	6.98e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—hematologic cancer	4.97e-08	6.97e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—hematologic cancer	4.97e-08	6.97e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—hematologic cancer	4.97e-08	6.97e-07	CbGpPWpGaD
Sunitinib—FYN—Immune System—HRAS—hematologic cancer	4.96e-08	6.96e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—hematologic cancer	4.96e-08	6.95e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—hematologic cancer	4.96e-08	6.95e-07	CbGpPWpGaD
Sunitinib—FYN—Disease—PIK3CA—hematologic cancer	4.95e-08	6.95e-07	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—hematologic cancer	4.94e-08	6.93e-07	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—hematologic cancer	4.94e-08	6.93e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—hematologic cancer	4.94e-08	6.93e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HRAS—hematologic cancer	4.94e-08	6.92e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SDC1—hematologic cancer	4.93e-08	6.91e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—hematologic cancer	4.93e-08	6.91e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CDKN1A—hematologic cancer	4.93e-08	6.91e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PIK3CA—hematologic cancer	4.93e-08	6.91e-07	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—hematologic cancer	4.92e-08	6.9e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PTEN—hematologic cancer	4.92e-08	6.9e-07	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—hematologic cancer	4.91e-08	6.89e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CDKN1A—hematologic cancer	4.9e-08	6.87e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PTEN—hematologic cancer	4.89e-08	6.86e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—KRAS—hematologic cancer	4.88e-08	6.84e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—HRAS—hematologic cancer	4.87e-08	6.83e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EP300—hematologic cancer	4.86e-08	6.82e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK3—hematologic cancer	4.85e-08	6.8e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SRC—hematologic cancer	4.85e-08	6.8e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCND1—hematologic cancer	4.84e-08	6.79e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK3—hematologic cancer	4.84e-08	6.78e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—JUN—hematologic cancer	4.83e-08	6.78e-07	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—hematologic cancer	4.82e-08	6.76e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK8—hematologic cancer	4.81e-08	6.75e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK8—hematologic cancer	4.78e-08	6.71e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—hematologic cancer	4.77e-08	6.69e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CREBBP—hematologic cancer	4.76e-08	6.67e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—HRAS—hematologic cancer	4.75e-08	6.67e-07	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—hematologic cancer	4.75e-08	6.66e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTEN—hematologic cancer	4.74e-08	6.65e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—KRAS—hematologic cancer	4.73e-08	6.64e-07	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—hematologic cancer	4.73e-08	6.64e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SRC—hematologic cancer	4.73e-08	6.63e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—hematologic cancer	4.72e-08	6.63e-07	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PIK3CA—hematologic cancer	4.72e-08	6.63e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—hematologic cancer	4.72e-08	6.62e-07	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HRAS—hematologic cancer	4.72e-08	6.62e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—hematologic cancer	4.72e-08	6.62e-07	CbGpPWpGaD
Sunitinib—JAK2—Disease—PIK3CA—hematologic cancer	4.71e-08	6.6e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—hematologic cancer	4.7e-08	6.6e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—hematologic cancer	4.7e-08	6.6e-07	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—hematologic cancer	4.7e-08	6.6e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTEN—hematologic cancer	4.7e-08	6.59e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—hematologic cancer	4.69e-08	6.58e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EP300—hematologic cancer	4.69e-08	6.58e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CDKN1A—hematologic cancer	4.68e-08	6.57e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—KRAS—hematologic cancer	4.68e-08	6.56e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—STAT3—hematologic cancer	4.67e-08	6.56e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PTEN—hematologic cancer	4.67e-08	6.55e-07	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—hematologic cancer	4.67e-08	6.55e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EP300—hematologic cancer	4.66e-08	6.54e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NRAS—hematologic cancer	4.66e-08	6.54e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—hematologic cancer	4.66e-08	6.54e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—hematologic cancer	4.66e-08	6.53e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—hematologic cancer	4.66e-08	6.53e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—hematologic cancer	4.61e-08	6.46e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—hematologic cancer	4.61e-08	6.46e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—KRAS—hematologic cancer	4.59e-08	6.44e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—KRAS—hematologic cancer	4.59e-08	6.44e-07	CbGpPWpGaD
Sunitinib—FYN—Disease—HRAS—hematologic cancer	4.58e-08	6.43e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK8—hematologic cancer	4.57e-08	6.41e-07	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—hematologic cancer	4.57e-08	6.41e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—STAT3—hematologic cancer	4.56e-08	6.4e-07	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—hematologic cancer	4.56e-08	6.4e-07	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—hematologic cancer	4.56e-08	6.4e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SRC—hematologic cancer	4.56e-08	6.39e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—hematologic cancer	4.56e-08	6.39e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—HRAS—hematologic cancer	4.56e-08	6.39e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NRAS—hematologic cancer	4.55e-08	6.38e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—hematologic cancer	4.55e-08	6.38e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—hematologic cancer	4.55e-08	6.38e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SRC—hematologic cancer	4.53e-08	6.36e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—EP300—hematologic cancer	4.52e-08	6.34e-07	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—hematologic cancer	4.51e-08	6.33e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CD—hematologic cancer	4.51e-08	6.33e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—EP300—hematologic cancer	4.48e-08	6.29e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PIK3CA—hematologic cancer	4.48e-08	6.28e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK3—hematologic cancer	4.47e-08	6.26e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EP300—hematologic cancer	4.46e-08	6.25e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—hematologic cancer	4.45e-08	6.25e-07	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—hematologic cancer	4.44e-08	6.23e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—hematologic cancer	4.44e-08	6.23e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—hematologic cancer	4.42e-08	6.19e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—STAT3—hematologic cancer	4.4e-08	6.17e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NRAS—hematologic cancer	4.39e-08	6.15e-07	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—hematologic cancer	4.38e-08	6.15e-07	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—hematologic cancer	4.38e-08	6.15e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—STAT3—hematologic cancer	4.37e-08	6.13e-07	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—HRAS—hematologic cancer	4.37e-08	6.13e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NRAS—hematologic cancer	4.36e-08	6.12e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—hematologic cancer	4.36e-08	6.12e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—hematologic cancer	4.36e-08	6.11e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—KRAS—hematologic cancer	4.36e-08	6.11e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK3—hematologic cancer	4.36e-08	6.11e-07	CbGpPWpGaD
Sunitinib—JAK2—Disease—HRAS—hematologic cancer	4.35e-08	6.11e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PIK3CA—hematologic cancer	4.35e-08	6.1e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—KRAS—hematologic cancer	4.35e-08	6.1e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—hematologic cancer	4.34e-08	6.09e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—hematologic cancer	4.33e-08	6.08e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SRC—hematologic cancer	4.33e-08	6.08e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—hematologic cancer	4.33e-08	6.08e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—hematologic cancer	4.3e-08	6.03e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PIK3CA—hematologic cancer	4.3e-08	6.03e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3R1—hematologic cancer	4.26e-08	5.97e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—hematologic cancer	4.24e-08	5.94e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—hematologic cancer	4.23e-08	5.93e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—hematologic cancer	4.22e-08	5.92e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PIK3CA—hematologic cancer	4.22e-08	5.92e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PIK3CA—hematologic cancer	4.22e-08	5.92e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—hematologic cancer	4.21e-08	5.9e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK3—hematologic cancer	4.2e-08	5.89e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—hematologic cancer	4.2e-08	5.89e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CD44—hematologic cancer	4.19e-08	5.88e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NQO1—hematologic cancer	4.19e-08	5.88e-07	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—hematologic cancer	4.18e-08	5.87e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—STAT3—hematologic cancer	4.18e-08	5.86e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK3—hematologic cancer	4.18e-08	5.86e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NRAS—hematologic cancer	4.17e-08	5.85e-07	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—hematologic cancer	4.17e-08	5.85e-07	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—hematologic cancer	4.16e-08	5.84e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—hematologic cancer	4.16e-08	5.83e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—HRAS—hematologic cancer	4.15e-08	5.81e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—hematologic cancer	4.08e-08	5.73e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—hematologic cancer	4.08e-08	5.72e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—hematologic cancer	4.08e-08	5.72e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—hematologic cancer	4.07e-08	5.72e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—hematologic cancer	4.06e-08	5.7e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—hematologic cancer	4.05e-08	5.69e-07	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—hematologic cancer	4.05e-08	5.67e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—HRAS—hematologic cancer	4.02e-08	5.64e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—hematologic cancer	4.02e-08	5.64e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—KRAS—hematologic cancer	4.01e-08	5.63e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PIK3CA—hematologic cancer	4e-08	5.62e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PIK3CA—hematologic cancer	3.99e-08	5.6e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK3—hematologic cancer	3.99e-08	5.6e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—HRAS—hematologic cancer	3.97e-08	5.57e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—hematologic cancer	3.97e-08	5.57e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYCS—hematologic cancer	3.97e-08	5.56e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.94e-08	5.53e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CB—hematologic cancer	3.93e-08	5.51e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—KRAS—hematologic cancer	3.92e-08	5.49e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—HRAS—hematologic cancer	3.9e-08	5.47e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—HRAS—hematologic cancer	3.9e-08	5.47e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—hematologic cancer	3.88e-08	5.45e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—hematologic cancer	3.87e-08	5.43e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—hematologic cancer	3.87e-08	5.43e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.87e-08	5.43e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—hematologic cancer	3.86e-08	5.42e-07	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—hematologic cancer	3.86e-08	5.41e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—hematologic cancer	3.85e-08	5.4e-07	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—hematologic cancer	3.85e-08	5.39e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—hematologic cancer	3.8e-08	5.34e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—KRAS—hematologic cancer	3.77e-08	5.29e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—KRAS—hematologic cancer	3.75e-08	5.27e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—hematologic cancer	3.74e-08	5.24e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—hematologic cancer	3.74e-08	5.24e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—HRAS—hematologic cancer	3.7e-08	5.2e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—HRAS—hematologic cancer	3.69e-08	5.18e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CA—hematologic cancer	3.69e-08	5.17e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—hematologic cancer	3.66e-08	5.13e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CA—hematologic cancer	3.6e-08	5.05e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CREBBP—hematologic cancer	3.59e-08	5.04e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—KRAS—hematologic cancer	3.59e-08	5.03e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—hematologic cancer	3.57e-08	5e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—hematologic cancer	3.55e-08	4.98e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—hematologic cancer	3.55e-08	4.97e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—hematologic cancer	3.54e-08	4.96e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—hematologic cancer	3.51e-08	4.92e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.5e-08	4.9e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—hematologic cancer	3.48e-08	4.88e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CA—hematologic cancer	3.47e-08	4.86e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CA—hematologic cancer	3.45e-08	4.84e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—hematologic cancer	3.45e-08	4.83e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—hematologic cancer	3.45e-08	4.83e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HRAS—hematologic cancer	3.41e-08	4.78e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.4e-08	4.77e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTEN—hematologic cancer	3.4e-08	4.77e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—hematologic cancer	3.36e-08	4.71e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—hematologic cancer	3.35e-08	4.71e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CA—hematologic cancer	3.34e-08	4.69e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—hematologic cancer	3.34e-08	4.68e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HRAS—hematologic cancer	3.33e-08	4.67e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CA—hematologic cancer	3.32e-08	4.65e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.31e-08	4.64e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CA—hematologic cancer	3.3e-08	4.62e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—hematologic cancer	3.27e-08	4.59e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—hematologic cancer	3.26e-08	4.58e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—hematologic cancer	3.26e-08	4.58e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—EP300—hematologic cancer	3.24e-08	4.54e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.21e-08	4.51e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.21e-08	4.51e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.21e-08	4.51e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HRAS—hematologic cancer	3.21e-08	4.5e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HRAS—hematologic cancer	3.19e-08	4.48e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—hematologic cancer	3.19e-08	4.47e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—hematologic cancer	3.19e-08	4.47e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—hematologic cancer	3.07e-08	4.31e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—hematologic cancer	3.05e-08	4.28e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HRAS—hematologic cancer	3.05e-08	4.28e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—hematologic cancer	3.01e-08	4.22e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.97e-08	4.16e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—hematologic cancer	2.94e-08	4.12e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—hematologic cancer	2.92e-08	4.09e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.84e-08	3.98e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—hematologic cancer	2.83e-08	3.97e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—hematologic cancer	2.82e-08	3.95e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—hematologic cancer	2.73e-08	3.83e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—hematologic cancer	2.71e-08	3.8e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—hematologic cancer	2.69e-08	3.78e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTEN—hematologic cancer	2.56e-08	3.6e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—EP300—hematologic cancer	2.44e-08	3.43e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.4e-08	3.36e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.39e-08	3.35e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.21e-08	3.1e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.1e-08	2.94e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—hematologic cancer	2.07e-08	2.9e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.98e-08	2.78e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—hematologic cancer	1.96e-08	2.75e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.83e-08	2.56e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.81e-08	2.54e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTEN—hematologic cancer	1.58e-08	2.22e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—EP300—hematologic cancer	1.51e-08	2.11e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—hematologic cancer	1.48e-08	2.07e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.11e-08	1.56e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—hematologic cancer	9.1e-09	1.28e-07	CbGpPWpGaD
